12 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ADVANCED TURBO DRIVE SYSTEM

FDA 510(k)
FDA Class 1 ·General, Plastic Surgery

PULSE

FDA UDI
Nuvasive, Inc.·00195377154002·PULSE Instruments Plus Tray

ADVANCE®

FDA UDI
Microport Orthopedics Inc.·M684K00505191·

Marina Medical

FDA UDI
MARINA MEDICAL INSTRUMENTS, INC.·00840306814693·Bandage Scissors, Large Rings, 20cm

Nitinol Staple, Elastic Staple Small-Asymmetrical, Sterile R, Model #: a) ES-10x13x15; b) ES-10x16x19; c) ES-10x17x19; d) ES-12x13x15; e) ES-12x15x17; f) ES-12x16x19; g) ES-15x13x16

FDA Enforcement
Class II ·Terminated·TriMed Inc.·June 27, 2018

MAGNUM FLOW IRRIGATION SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

GLUCANPRO

FDA 510(k)
FDA Unclassified ·Unknown

DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·March 3, 2025

SYNCHROMED II

FDA Adverse Event
Injury ·MEDTRONIC NEUROMODULATION·Product code LKK·April 10, 2013

QUICKSITE LV

FDA Adverse Event
Injury ·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code DXY·May 27, 2008

AC POWER MODULE

FDA Adverse Event
Malfunction ·PHILIPS HEALTHCARE·Product code MKJ·April 5, 2011

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014